Cornelis H.W. Koks

1.8k total citations
38 papers, 1.3k citations indexed

About

Cornelis H.W. Koks is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Cornelis H.W. Koks has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Cornelis H.W. Koks's work include HIV/AIDS drug development and treatment (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and HIV Research and Treatment (8 papers). Cornelis H.W. Koks is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and HIV Research and Treatment (8 papers). Cornelis H.W. Koks collaborates with scholars based in Netherlands, New Zealand and Belgium. Cornelis H.W. Koks's co-authors include Jos H. Beijnen, Jan W. Mulder, P. L. Meenhorst, Linda R. Tulner, Jos P.C.M. van Campen, David M. Burger, Suzanne V. Frankfort, A. Bult, Alwin D. R. Huitema and Jan H.M. Schellens and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, AIDS and Atherosclerosis.

In The Last Decade

Cornelis H.W. Koks

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornelis H.W. Koks Netherlands 18 466 221 218 192 190 38 1.3k
Antonio J. Carcas Spain 22 349 0.7× 306 1.4× 211 1.0× 55 0.3× 339 1.8× 116 1.7k
Christina L. Aquilante United States 26 366 0.8× 468 2.1× 225 1.0× 87 0.5× 829 4.4× 87 2.3k
Y. A. Hekster Netherlands 27 621 1.3× 609 2.8× 320 1.5× 56 0.3× 217 1.1× 116 2.3k
Charles la Porte Canada 13 478 1.0× 99 0.4× 199 0.9× 166 0.9× 49 0.3× 30 970
Kevin T. Batty Australia 25 331 0.7× 242 1.1× 253 1.2× 206 1.1× 451 2.4× 102 2.2k
Sara Gibbons United Kingdom 22 1.3k 2.8× 416 1.9× 332 1.5× 72 0.4× 194 1.0× 34 1.8k
Peter I. Pillans Australia 29 221 0.5× 329 1.5× 200 0.9× 298 1.6× 128 0.7× 93 2.2k
Klaus‐Dieter Riedel Germany 22 488 1.0× 278 1.3× 288 1.3× 24 0.1× 363 1.9× 36 1.5k
Eric Decloedt South Africa 19 659 1.4× 243 1.1× 272 1.2× 43 0.2× 61 0.3× 85 1.3k
Lynda S. Welage United States 23 150 0.3× 310 1.4× 185 0.8× 78 0.4× 223 1.2× 72 1.8k

Countries citing papers authored by Cornelis H.W. Koks

Since Specialization
Citations

This map shows the geographic impact of Cornelis H.W. Koks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelis H.W. Koks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelis H.W. Koks more than expected).

Fields of papers citing papers by Cornelis H.W. Koks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelis H.W. Koks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelis H.W. Koks. The network helps show where Cornelis H.W. Koks may publish in the future.

Co-authorship network of co-authors of Cornelis H.W. Koks

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelis H.W. Koks. A scholar is included among the top collaborators of Cornelis H.W. Koks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelis H.W. Koks. Cornelis H.W. Koks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Jos P.C.M. van Campen, et al.. (2010). Contraindications for Anticoagulation in Older Patients with Atrial Fibrillation: A Narrative Review. Current Drug Safety. 5(3). 223–233. 6 indexed citations
3.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Jos P.C.M. van Campen, et al.. (2009). Treatment of hypertension in an elderly outpatient population in the Netherlands. ˜The œAmerican journal of geriatric pharmacotherapy. 7(4). 204–209. 4 indexed citations
4.
Frankfort, Suzanne V., Bregje A. Appels, A de Boer, et al.. (2006). Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. Pharmacoepidemiology and Drug Safety. 16(5). 545–551. 17 indexed citations
5.
Frankfort, Suzanne V., Linda R. Tulner, Jos P.C.M. van Campen, Cornelis H.W. Koks, & Jos H. Beijnen. (2006). Evaluation of Pharmacotherapy in Geriatric Patients after Performing Complete Geriatric Assessment at a??Diagnostic Day Clinic. Clinical Drug Investigation. 26(3). 169–174. 17 indexed citations
6.
Frankfort, Suzanne V., Bregje A. Appels, Linda R. Tulner, et al.. (2006). Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting. International Journal of Clinical Practice. 60(6). 646–654. 15 indexed citations
7.
Frankfort, Suzanne V., Linda R. Tulner, Jos P.C.M. van Campen, Cornelis H.W. Koks, & Jos H. Beijnen. (2006). The effect of admission to a geriatric ward on medication use: 2002 versus 1985. Pharmacoepidemiology and Drug Safety. 15(8). 602–606.
8.
Frankfort, Suzanne V., Bregje A. Appels, Anthonius de Boer, et al.. (2005). Discontinuation of rivastigmine in routine clinical practice. International Journal of Geriatric Psychiatry. 20(12). 1167–1171. 14 indexed citations
9.
Maat, Monique M. R. de, Anthonius de Boer, Cornelis H.W. Koks, et al.. (2004). Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. Journal of Clinical Pharmacy and Therapeutics. 29(2). 121–130. 49 indexed citations
10.
Maat, Monique M. R. de, Teun M. Post, D. Jonker, et al.. (2003). Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001. Clinical Drug Investigation. 23(1). 45–53. 1 indexed citations
11.
Koks, Cornelis H.W.. (2002). PROGNOSTIC FACTORS FOR THE CLINICAL EFFECTIVENESS OF FLUCONAZOLE IN THE TREATMENT OF ORAL CANDIDIASIS IN HIV-1-INFECTED INDIVIDUALS. Pharmacological Research. 46(1). 89–94. 5 indexed citations
12.
Frankfort, Suzanne V., Ron A. A. Mathôt, Jan W. Mulder, et al.. (2002). Discrepancies between Medical and Pharmacy Records for Patients on Anti-HIV Drugs. Annals of Pharmacotherapy. 36(3). 410–415. 11 indexed citations
13.
14.
Koks, Cornelis H.W., Kristel M. L. Crommentuyn, Richard M. W. Hoetelmans, Ron A. A. Mathôt, & Jos H. Beijnen. (2001). Can Fluconazole Concentrations in Saliva Be Used for Therapeutic Drug Monitoring?. Therapeutic Drug Monitoring. 23(4). 449–453. 14 indexed citations
15.
Koks, Cornelis H.W., Kristel M. L. Crommentuyn, Richard M. W. Hoetelmans, et al.. (2001). The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals. British Journal of Clinical Pharmacology. 51(6). 631–635. 19 indexed citations
16.
Koks, Cornelis H.W., et al.. (1996). Etoposide phosphate, the water soluble prodrug of etoposide. Pharmacy World & Science. 18(5). 163–170. 30 indexed citations
17.
Burger, David M., Pieter L. Meenhorst, Chris H.H. ten Napel, et al.. (1995). Limited sampling models for the antiretroviral agent didanosine. European Journal of Pharmaceutical Sciences. 3(1). 7–13. 1 indexed citations
18.
Burger, David M., Chris H.H. ten Napel, Jan W. Mulder, et al.. (1994). Pharmacokinetic variability of zidovudine in HIV-infected individuals. AIDS. 8(12). 1683–1690. 37 indexed citations
19.
Burger, David M., L.J.C. van Warmerdam, Hilde Rosing, et al.. (1993). Development and Validation of Limited-Sampling Models for the Antiretroviral Agent Zidovudine. Clinical Drug Investigation. 6(4). 189–197. 4 indexed citations
20.
Burger, David M., Pieter L. Meenhorst, Jan W. Mulder, et al.. (1993). Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV. AIDS. 7(12). 1581–1587. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio J. Carcas Breakdown of academic impact, for papers by Christina L. Aquilante Breakdown of academic impact, for papers by Y. A. Hekster Breakdown of academic impact, for papers by Charles la Porte Breakdown of academic impact, for papers by Kevin T. Batty Breakdown of academic impact, for papers by Sara Gibbons Breakdown of academic impact, for papers by Peter I. Pillans Breakdown of academic impact, for papers by Klaus‐Dieter Riedel Breakdown of academic impact, for papers by Eric Decloedt Breakdown of academic impact, for papers by Lynda S. Welage
Rankless by CCL
2026